CDK5RAP Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Originally developed as a CDK2 inhibitor, Roscovitine also inhibits CDK5 activity, potentially affecting its regulatory subunit interactions. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $77.00 $315.00 $658.00 | 1 | |
A natural compound that inhibits CDK5 and GSK-3β (Glycogen synthase kinase 3 beta), potentially affecting its regulatory subunit interactions. | ||||||
SNS-032 | 345627-80-7 | sc-364621 sc-364621A | 5 mg 10 mg | $169.00 $262.00 | ||
A potent and selective CDK2/7/9 inhibitor that also affects CDK5 activity, potentially affecting its regulatory subunit interactions. | ||||||
Butyrolactone I | 87414-49-1 | sc-201533 sc-201533A | 200 µg 1 mg | $120.00 $504.00 | 1 | |
A natural product that inhibits multiple CDKs, including CDK5, potentially affecting its regulatory subunit interactions. | ||||||
AT7519 | 844442-38-2 | sc-364416 sc-364416A sc-364416B sc-364416C | 5 mg 10 mg 100 mg 1 g | $207.00 $246.00 $1025.00 $3065.00 | 1 | |
A broad-spectrum inhibitor of multiple CDKs, including CDK5, potentially affecting its regulatory subunit interactions. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $242.00 $871.00 | 1 | |
A potent CDK1/2/5/9 inhibitor that blocks CDK5 function, potentially affecting its regulatory subunit interactions. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
A potent CDK1/2/5/7/9 inhibitor, originally developed as an anticancer agent, potentially affecting its regulatory subunit interactions. | ||||||
PHA-848125 | 802539-81-7 | sc-364581 sc-364581A | 5 mg 10 mg | $304.00 $555.00 | ||
An ATP-competitive inhibitor of CDK2/5/7/9, potentially affecting its regulatory subunit interactions. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Although primarily known as a CDK4/6 inhibitor, LEE011 can also inhibit CDK5 activity, potentially affecting its regulatory subunit interactions. | ||||||